Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Oruka Therapeutics, Inc. | 64,167 | reported | 18 May 2026 | tx 12+215,333−18,518 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 May 2026 | EXERCISE | Oruka Therapeutics, Inc. | 2,000 | 12.50 USD | 10b5-1 |
| 18 May 2026 | EXERCISE | Oruka Therapeutics, Inc. | 5,833 | 34.39 USD | 10b5-1 |
| 18 May 2026 | SALE | Oruka Therapeutics, Inc. | 4,190 | 58.34 USD | 10b5-1 |
| 18 May 2026 | SALE | Oruka Therapeutics, Inc. | 4,600 | 59.19 USD | 10b5-1 |
| 18 May 2026 | SALE | Oruka Therapeutics, Inc. | 800 | 60.34 USD | 10b5-1 |
| 18 May 2026 | SALE | Oruka Therapeutics, Inc. | 700 | 61.16 USD | 10b5-1 |
| 18 May 2026 | EXERCISE | Oruka Therapeutics, Inc. | 2,000 | 0.00 USD | 10b5-1deriv |
| 18 May 2026 | EXERCISE | Oruka Therapeutics, Inc. | 5,833 | 0.00 USD | 10b5-1deriv |
| 16 Mar 2026 | SALE | Oruka Therapeutics, Inc. | 395 | 41.30 USD | |
| 23 Jan 2026 | GRANT_AWARD | Oruka Therapeutics, Inc. | 17,500 | 0.00 USD | |
| 23 Jan 2026 | GRANT_AWARD | Oruka Therapeutics, Inc. | 70,000 | 0.00 USD | deriv |
| 22 Jan 2025 | GRANT_AWARD | Oruka Therapeutics, Inc. | 120,000 | 0.00 USD | deriv |